Late effects of hematopoietic stem cell transplantation

Hematology

Volumn 5, Issue 3, 2000, Pages 209-222

  Kansu, E ^a   Sullivan, K M ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; INACTIVATED VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PENTAMIDINE; PNEUMOCOCCUS VACCINE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THALIDOMIDE; VARICELLA ZOSTER VACCINE;

ARTICLE; CATARACT; GONAD DYSFUNCTION; GRAFT VERSUS HOST REACTION; GYNECOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; INFECTION; NEUROLOGICAL COMPLICATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; QUALITY OF LIFE; VIRUS PNEUMONIA;

EID: 0033785892     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245332.2000.11746510     Document Type: Article

References (65)

1. Research potential of the ABMTR Database
2. Chronic graft-versus-host disease and other late complications of bone marrow transplantation
3. Regimen-related toxicity In patients undergoing bone marrow transplantation
4. Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation
5. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia
6. Late complications of allogeneic and autologous marrow transplantation
7. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation
8. Growth and development after bone marrow transplantation
9. Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation
10. Gonadal function after bone marrow transplantation in adult male and female patients
11. Late effects on gonadal function of cyclophosphamide, total-body, and marrow transplantation
12. Clinical longitudinal standards for height, weight, weight velocity, and stages of puberty
13. Gynecological abnormalities following allogeneic bone marrow transplantation
14. Fertility, pregnancies and offspring complications after bone marrow transplantation
15. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation
16. Immunologic reconstitution after human marrow grafting
17. Analysis of late infections after human bone marrow transplantation : Role of genotypic nonidentity between marrow donor and recipient and of non-specific suppressor cells in patients with chronic graft-versus-host disease
18. Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone-marrow support
19. Long lasting IgG subclass and anti-bacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation
20. Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation
21. Analysis of late infections in 89 long-term survivors of bone marrow transplantation
22. Pneumococcal infections after human bone marrow transplantation
23. Infections in recipients of blood and marrow transplantation
24. Pneumococcal infections after human bone marrow transplantation
25. Infection with varicella-zoster virus after marrow transplantation
26. Herpes Zoster infection after autologous bone marrow transplantation
27. Allogeneic peripheral blood stem cell transplantation may be associated with a high-risk of chronic graft-versus-host disease
28. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation
29. Graft-versus-host disease
30. Chronic graft-versus-host disease
31. Chronic cutaneous graft-versus-host disease in man
32. Recognition, incidence and management of oral graft-versus host disease
33. Risk factors for airflow obstruction in recipients of bone marrow transplants
34. Obstructive lung disease after allogeneic marrow transplantation
35. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host of the liver
36. Fasciitis in chronic graft-versus-host disease
37. Esophageal abnormalities in chronic graft-versus-host disease in humans
38. Intestinal and hepatic complications of human bone marrow transplantation
39. Early and late interstitial pnemonia following human bone marrow transplantation
40. Chronic graft-versus-host disease (GVHD) following unrelated donor transplantation
41. Impact of pre-transplant Interferon-alpha on outcome of unrelated donor marrow transplants for chronic myeloid leukemia (CML) in first chronic phase
42. Prednisone and azathioprine compared with prednisone and placebo for the treatment of chronic graft-versus-host disease: Prognostic prolonged thrombocytopenia after allogeneic marrow transplantation
43. Thalidomide for the treatment of chronic graft-versus-host disease
44. Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): Safety analysis
45. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-versus-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery
46. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation
47. Avascular necrosis of bone after allogeneic bone marrow transplantation: Clinical findings, incidence and risk factors
48. Bone density loss during treatment of chronic GVHD
49. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia
50. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone
51. Malignant tumors occurring after treatment of aplastic anemia
52. Malignancies after marrow transplantation for aplastic anemia and Fanconi Anemia: A joint Seattle and Paris analysis of results in 700 patients
53. Solid cancers after bone marrow transplantation
54. Relapse of acute leukema after marrow transplantation: Natural history and results of subsequent therapy
55. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens
56. Use of alpha-interferon for treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow Transplantation
57. And the Seattle Marrow Transplant Team. Anti-Leukemic Effect of Chronic Graft-versus-Host disease
58. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms
59. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
60. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
61. Health, functional status and employment of adult survivors of bone marrow transplantation
62. Dynamic assessment of quality of life after autologous bone marrow transplantation
63. Extended follow-up of 212 long-term allogeneic bone marrow transplant survivors
64. Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning
65. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation